Latest Anticonvulsants Stories
The personal injury law firm of d’Oliveira & Associates has issued an infographic on Stevens Johnson Syndrome, which details potential causes and serious conditions that may result from the syndrome. (PRWEB) May 18, 2013 According to the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), also known as Toxic Epidermal Necrolysis, is a severe allergic reaction usually to medicine (i). The first signs of SJS involve flu-like symptoms but it can quickly advance...
According to court data, on April 29, 2013, several plaintiffs filed a lawsuit in Illinois Southern District Court alleging serious birth defects caused by their mothers’ ingestion of Depakote during pregnancy. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) May 07, 2013 AttorneyOne.com, a...
redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) is warning women who are of childbearing age not to use several varieties of migraine medicine which could decrease the intelligence of their babies if taken while pregnant. According to Reuters, the medications – Abbott Laboratories' Depacon, Depakote, Depakote CP, Depakote ER and Depakene, as well as Noven Therapeutics LLC's Stavzor and the generic versions of each drug – all contain...
MOUNTAIN VIEW, Calif., May 6, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company has been selected to present its AZ-002 (Staccato(®) alprazolam) program at the Pipeline Session of the Antiepileptic Drug and Device Trials (AED) XII Conference, the premier conference devoted to convening the full spectrum of research, industry and regulatory expertise in the epilepsy field with the objective of accelerating the most promising epilepsy...
Two Research Abstracts Accepted for the International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting BOWIE, Md., May 1, 2013 /PRNewswire/ -- Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced two comparative effectiveness research studies to be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18(th) Annual International Meeting May 18-22 in New Orleans, La. The...
Klitgaard to be Honored at Antiepileptic Drug and Device Trials XII Conference in Miami May 15-17 LANDOVER, Md., April 30, 2013 /PRNewswire-USNewswire/ -- The Epilepsy Foundation announced today that Henrik Klitgaard, Ph.D., Vice President and Fellow, Neurosciences Therapeutic Area, UCB, has been named the recipient of the Epilepsy Therapy Project Lifetime Accelerator Award in recognition of his commitment and contributions to the field of epilepsy and to the people affected by it....
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA. The authors caution that these findings must be balanced against the treatment benefits for women who require valproate for epilepsy control. "Anti-epileptic drug exposure during pregnancy has been associated with an increased risk for...
A new study published on March 6th, 2013 in the journal Acta Neurologica Scandinavica revealed that valproate (Depakote) is linked with birth defects. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) April 12, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and is...
Greater Reduction in Pain Intensity is One of the Greatest Unmet Needs in Postherpetic Neuralgia, According to a New Report from Decision Resources BURLINGTON, Mass., April 9, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that reduction in pain intensity is one of the attributes that most influences their decisions regarding prescribing...
If you or anyone you know has taken Topamax during a pregnancy, the attorneys at d'Oliveira & Associates urge you to contact them immediately. (PRWEB) March 23, 2013 Topamax is a popular anticonvulsant prescription drug manufactured by the Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical. Originally approved by The U.S. Food and Drug Administration (FDA) in 1996 to treat persons experiencing epileptic seizures, the drug has since been approved as an anti-migraine drug...
